within Pharmacolibrary.Drugs.ATC.J;

model J04AK08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.53,
    Cl             = 0.26,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.18,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 10.020000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Pretomanid is a nitroimidazooxazine-class antibacterial drug used as part of combination therapy for the treatment of extensively drug-resistant, treatment-intolerant or non-responsive multidrug-resistant pulmonary tuberculosis in adults. It is approved by the US FDA (2019) and EMA as a component of specific multidrug regimens.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration, fasted or fed conditions, both sexes.</p><h4>References</h4><ol><li>Ilaria Motta, Martin Boeree, Dumitru Chesov, Keertan Dheda, Gunar Günther, Charles Robert Horsburgh, Yousra Kherabi, Christoph Lange, Christian Lienhardt, Helen M McIlleron, Nicholas I Paton, Helen R Stagg, Guy Thwaites, Zarir Udwadia, Reinout Van Crevel, Gustavo E Velásquez, Robert J Wilkinson, Lorenzo Guglielmetti,Recent advances in the treatment of tuberculosis.,Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,2024<a href='https://pubmed.ncbi.nlm.nih.gov/37482332/'>https://pubmed.ncbi.nlm.nih.gov/37482332/</a></li><li>Niklas Koehler, Sönke Andres, Matthias Merker, Viola Dreyer, Agnieszka John, Martin Kuhns, David Krieger, Eva Choong, Nick Verougstraete, Pia Abel Zur Wiesch, Sebastian G Wicha, Christina König, Barbara Kalsdorf, Patricia M Sanchez Carballo, Dagmar Schaub, Jim Werngren, Thomas Schön, Charles A Peloquin, Nicolas Schönfeld, Alain G Verstraete, Laurent A Decosterd, Rob Aarnoutse, Stefan Niemann, Florian P Maurer, Christoph Lange,Pretomanid-resistant tuberculosis.,The Journal of infection,2023<a href='https://pubmed.ncbi.nlm.nih.gov/36738862/'>https://pubmed.ncbi.nlm.nih.gov/36738862/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J04AK08;
